Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in Nepal

BMC Infectious Diseases

Table 2 Use of medication for AEFIs by severity

Round	Name of medication	Adverse events after COVID-19 vaccination				Percentage (%)	95% CI
Round	Name of medication	Mild	Moderate	Severe	Frequency^a	Percentage (%)	95% CI
I	Paracetamol only	44	47	6	97	77.6	70.3–84.9
	Combination of Paracetamol and other NSAIDs^b	5	15	2	22	17.6	10.9–24.3
	Combination of Paracetamol and drugs other than NSAIDs^c	0	6	0	6	4.8	1.1–8.5
II	Paracetamol only	10	1	0	11	91.7	83.3–100
II	Combination of Paracetamol and other NSAIDs^b	1	0	0	1	8.3	0–16.7

^aTotal frequency of medicine use on the first round was 125 and on the second round was 12
^bCombination of Paracetamol and NSAIDS = Flexion (Paracetamol + Ibuprofen), Flexion (Paracetamol + Ibuprofen) + Nimesulide, Nimesulide + Paracetamol
^cCombination of Paracetamol and drug other than NSAIDS = Paracetamol + Sinex (Paracetamol + phenylpropanolamine + chlorpheniramine + caffeine), Codopar (Paracetamol + codeine phosphate), Paracetamol + Cough syrup, Paracetamol + Metronidazole, Paracetamol + Tizanidine

ISSN: 1471-2334